Cargando…
The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
Biomarkers for neurodegenerative diseases should reflect the central pathogenic processes of the diseases. The field of clinical proteomics is especially well suited for discovery of biomarkers in cerebrospinal fluid (CSF), which reflects the proteins in the brain under healthy conditions as well as...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850612/ https://www.ncbi.nlm.nih.gov/pubmed/15920295 http://dx.doi.org/10.1155/2005/848676 |